Sanofi taps new startup ScionxBio for long-acting RNA
ScionxBio has inked a deal with French drugmaker Sanofi — its first partnership since splitting from parent company Eleven Therapeutics a few months ago. Under the agreement, ScionxBio will screen Sanofi’s mRNA candidates through its so-called ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.